title: Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules.
abstract: Edible vaccines that can be made widely available and easily administered could bring great benefit to the worldwide battle against pandemic viral infections. They can be used not only for the vaccination of humans and domesticated animals, but also for wild herds and live stock which are otherwise difficult to vaccinate. In this study, we report the development of an edible mini-capsule form of live, non-persisting, recombinant Lactococcus lactis (L. lactis) vaccine against the highly virulent influenza H5N1 strain. Recombinant L. lactis-based H5N1 HA antigen expression constructs were made and shown to be able to induce higher levels of HA-specific serum IgG and fecal IgA antibody production after oral administration. The vectors were then formulated into a mini-capsule dosage form and fed to mouse. Four doses of oral administration rendered complete protection of the mouse against lethal challenges of H5N1 virus.
authors.affiliation: School of Life Science and Technology, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
authors.forename: Han
authors.initials: H
authors.lastname: Lei
authors.forename: Yuhong
authors.initials: Y
authors.lastname: Xu
authors.forename: Jian
authors.initials: J
authors.lastname: Chen
authors.forename: Xiaohui
authors.initials: X
authors.lastname: Wei
authors.forename: Dominic Man-Kit
authors.initials: DM
authors.lastname: Lam
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D002214:Capsules / Q000008:administration & dosage; D005822:Genetic Vectors; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000235:genetics / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D053124:Influenza A Virus, H5N1 Subtype / Q000235:genetics / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D013294:Lactococcus lactis / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D009976:Orthomyxoviridae Infections / Q000517:prevention & control* / Q000821:virology; D013601:T-Lymphocytes / Q000276:immunology; D013608:Tablets, Enteric-Coated / Q000008:administration & dosage*; D022462:Vaccines, Edible / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D002214:Capsules; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007252:Influenza Vaccines; D013608:Tablets, Enteric-Coated; D022462:Vaccines, Edible; D014614:Vaccines, Synthetic